Since the discovery of antimicrobial agents, microorganisms have developed virtually unlimited resistance to them.1 Hospitals and particularly intensive care units are an important breeding ground for the development of antibiotic-resistant bacteria. This is the consequence of heavy antibiotic use. In addition, a high-density patient population in frequent contact with health care staff and the attendant risk of cross-infection contributes to the spread of antibiotic-resistant micro-organisms. This in turn increases the morbidity and mortality associated with infections, and contributes to rising costs of health care.2,3 The aim of this study was to investigate the prevalence of antibiotic resistance among gram-negative bacteria in relation to antibiotic use in the intensive care unit (ICU) at the Royal Hospital, the main referral hospital in Oman.
Materials and MethodsThe Royal Hospital is a 630-bed tertiary care hospital consisting of major medical and surgical departments, in addition to specialized units such as intensive care, neonatal, renal, cardiac and oncology. The intensive care unit (ICU) at the Royal Hospital is a general unit admitting both medical and surgical patients, and has a capacity of 12 beds divided between adults and pediatrics.
Specimen Collection and Identification of IsolatesOne hundred consecutive gram-negative bacterial isolates from different sites were collected from patients admitted to the adult ICU at the Royal Hospital. The clinical significance of the isolates was confirmed by analysis of patients' records and discussion with the treating clinician. All bacterial strains were identified by their colonial morphology, gram reaction, the oxidized and other biochemical reactions as performed by either API 20E, or API 20NE (bioMerieux, France).
Susceptibility TestingThe susceptibilities of the strains to 12 antibiotics (co-amoxiclav, cefuroxime, cefotaxime, ceftriaxone, ceftazidime, aztreonam, piperacillin, piperacillin/tazobactam, imipenem, gentamicin, amikacin, and ciprofloxacin) were performed by determining the minimum inhibitory concentration (MIC), using the E-test (AB BIODISK, Sweden), with E. coli NCTC 10418 and P. aeruginosa NCTC 10662 as controls. The interpretation standards for MICs of the NCCLS were used to determine antibiotic susceptibilities. 4 To detect extended spectrum β-lactamases (ESBL), ceftazidime-resistant strains of E. coli and Klebsiella spp. were further tested against ceftazidime/clavulanic acid. Isolates with a reduction of ceftazidime MIC by >3 two-fold dilutions in the presence of clavulanic acid were considered ESBL producers, and thus resistant to other cephalosporins.
Antibiotic ConsumptionThe quantities of antibiotics consumed in the ICU during the period of the study were obtained from the hospital pharmacy records, and the numbers of the patients discharged were obtained from the hospital records. The estimated days of antibiotic treatment were calculated from the antibiotic daily dose, the total amount consumed and the number of patients who lef...